COMMUNIQUÉS West-GlobeNewswire

Largest Shareholder of ZIVO Bioscience, Inc. to extend maturity date of its Convertible Debt
13/02/2018
KEEGO HARBOR, Mich., Feb. 12, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products derived from [...]
BioTelemetry, Inc. to Release Fourth Quarter 2017 Earnings Results on February 22, 2018
12/02/2018
MALVERN, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ) will release its fourth quarter 2017 earnings on Thursday, February 22 nd at 4:00 PM Eastern Time. The BioTelemetry quarterly conference [...]
Arcturus Therapeutics Appoints Dr. Christine Esau as Vice President of Research and Development
12/02/2018
Dr. Pad Chivukula Resigns as Chief Scientific Officer and Chief Operating Officer SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today announced [...]
Dova Pharmaceuticals to Present at Leerink Partners 7th Annual Global Healthcare Conference
12/02/2018
DURHAM, N.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Leerink Partners [...]
MPX Announces Inclusion in Horizons Emerging Marijuana Growers Index ETF
12/02/2018
TORONTO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce its inclusion in the newly created Horizons Emerging Marijuana Growers [...]
Catalyst Biosciences Announces Proposed Public Offering of Common Stock
12/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
3D Signatures Inc. Announces Changes To Its Board of Directors
12/02/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the " Company " or " 3DS ") [...]
Reata Announces Improvements in Kidney Function With Bardoxolone Methyl Maintained for Two Years in PAH Patients From LARIAT Trial
12/02/2018
Progressive loss of kidney function is a validated independent predictor of death and hospitalization in PAH patients Increases in eGFR from bardoxolone methyl treatment were maintained for two years Longest duration of [...]
Dova Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 15, 2018
12/02/2018
DURHAM, N.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) will host a conference call on Thursday, February 15, 2018 at 4:30 p.m. EST to discuss fourth quarter and full year 2017 [...]
Supernus to Host Fourth Quarter and Full Year 2017 Earnings Conference Call
12/02/2018
ROCKVILLE, Md., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central [...]
Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M for Patients with Relapsed or Refractory AML
12/02/2018
• Conference call to be held on Tuesday, February 13 th , 2018 at 4:30 PM ET to discuss planned Phase 1 clinical trial with Dr. Ehab Atallah • New trial represents expansion of Actinium’s CD33 program and increases [...]
K2M Group Holdings, Inc. to Participate in the 2018 RBC Capital Markets Global Healthcare Conference
12/02/2018
LEESBURG, Va., Feb. 12, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Affimed Announces Proposed Public Offering of Common Stock
12/02/2018
Heidelberg, Germany February 12, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that it has [...]
NEA Partner Ali Behbahani, M.D. Joins Genocea Biosciences’ Board of Directors
12/02/2018
CAMBRIDGE, Mass., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Ali Behbahani, M.D., a partner in [...]
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
12/02/2018
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) today announced that it intends to offer and sell shares of its common stock in an underwritten public [...]
Adverum Biotechnologies Announces Closing of $69 Million Public Offering
12/02/2018
MENLO PARK, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Onconova Therapeutics Announces Closing of $10 Million Underwritten Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Securities
12/02/2018
NEWTOWN, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug [...]
Franciscan Alliance, Circulation Unveil Non-Emergency Transportation Partnership
12/02/2018
MISHAWAKA, Indiana, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Hospital patients with ongoing medical conditions often are unable to receive the care they need because they don’t have transportation to see their doctors or make [...]
CROSSJECT :Information relative au nombre total de droits de vote et d'actions composant le capital social
12/02/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 12 février 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]

Pages